Notice of Results

RNS Number : 1079L

Microsaic Systems plc

04 September 2019

 

4 September 2019

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Notice of Results

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, will announce its results for the six months to 30 June 2019 on Monday 23 September 2019.

Enquiries:
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD	[phone]
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Tom Salvesen	[phone]
IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong Florence Chandler	[phone]

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's core product, the 4500 MiD®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.  

 

END

 

 

NORLLFLRAFIVIIA